If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFevertree Share News (FEVR)

Share Price Information for Fevertree (FEVR)

Share Price is delayed by 15 minutes
Get Live Data
800.00    -6.00 (-0.74%)
Bid:
801.00
Ask:
803.50
Spread: 2.50 (0.312%)
Market Cap: £904.90m
FEVR Live PriceLast checked at - London Stock Exchange

Intraday Fevertree Share Chart

Fevertree Drinks extends share buyback after solid start to year

Tue, 09th Jun 2026 11:26

(Alliance News) - Fevertree Drinks PLC on Tuesday announced a GBP30 million extension to its share buyback programme and said it remains confident of achieving full-year market expectations.

Ahead of Tuesday's annual general meeting, the London-based premium drink mixers manufacturer said it has made a "solid" start to the year and highlighted share gains across key markets including the UK, Europe and the US.

In response, shares in Fevertree Drinks jumped 6.3% to 807.00 pence each in London on Tuesday.

The partnership with Molson Coors has continued to progress well, backed by a new marketing campaign, while Australia has seen strong momentum, the firm added.

Glass costs for 2026 are "fully hedged" with respect to the impact of elevated energy costs, while the business has "significantly" extended coverage through 2027 and into 2028 for energy and increased its hedging position across all other significant cost components into 2027.

The extended buyback builds on the GBP100m programme completed in financial 2025 and the ongoing GBP30 million tranche, of which GBP18.9 million has been returned as of last Friday.

"With confidence in the company's prospects and a cash compounding business model, the board views a share buyback programme as a highly effective mechanism to drive shareholder value, alongside a progressive dividend policy, while enabling the business to continue to invest to accelerate growth," it said.

Chief Executive Tim Warrillow said despite the current geopolitical uncertainty, the firm remains confident in achieving market expectations for both adjusted revenue and earnings before interest, tax, depreciation and amortisation.

The group will announce interim results on September 10.

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Corporate News Retail

Related News

easyJet agrees in principle on Castlelake's sweetened £6.90 per share bid
8 hours ago

easyJet agrees in principle on Castlelake's sweetened £6.90 per share bid

July ​5 (Reuters) - ⁠British budget ​carrier ​easyJet said ‌on ⁠Sunday it ⁠has ​reached an agreement ​in ‌principle ​with Castlelake ‌on a sweetened £...

PRESS: Top DCC shareholders hit out at consortium bid - FT
14 hours ago

PRESS: Top DCC shareholders hit out at consortium bid - FT

(Alliance News) - A trio of DCC PLC investors believe a private equity bid undervalues the company, the Financial Times reported on Friday.

Fevertree News

IN BRIEF: Fevertree Drinks starts GBP30 million buyback extension
4 days ago

IN BRIEF: Fevertree Drinks starts GBP30 million buyback extension

Fevertree Drinks PLC - London-based maker of premium drink mixers - Fevertree starts the GBP30 million extension of its share buyback programme, which...

UK's FTSE 100 hits over three-week low as banks, energy stocks sag
9 Jun 2026

UK's FTSE 100 hits over three-week low as banks, energy stocks sag

June 9 (Reuters) - Britain's ​blue-chip FTSE ⁠100 hit its lowest since mid-May ​on Tuesday, bogged down by losses in heavyweight lenders HSBC and Stan...

Fevertree Drinks extends share buyback after solid start to year
9 Jun 2026

Fevertree Drinks extends share buyback after solid start to year

(Alliance News) - Fevertree Drinks PLC on Tuesday announced a GBP30 million extension to its share buyback programme and said it remains confident of ...

Fever-Tree toasts strong start to the year, shares fizz
9 Jun 2026

Fever-Tree toasts strong start to the year, shares fizz

(Sharecast News) - Shares in Fever-Tree Drinks fizzed on Tuesday, after the British business reaffirmed its full-year outlook and extended its share b...

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent
9 Jun 2026

LONDON BRIEFING: GSK agrees to buy US cancer drug maker Nuvalent

(Alliance News) - GSK agrees to buy US cancer treatment firm Nuvalent for USD10.6 billion, AstraZeneca advances its own weight-loss treatment while Be...